Collectively, these results demonstrate that inhibition of mTOR activity significantly potentiates etoposide-mediated cell death in breast cancer, suggesting that breast cancer cells may rely on the mTORC2-Chk1 pathway for survival. Here, MTOR is linked to breast cancer.